{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Xiaotong Zhu"}, {"accession": "MS:1000589", "name": "contact email", "value": "zhuxt@shanghaitech.edu.cn"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "ShanghaiTech University"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Gaofeng Fan"}, {"accession": "MS:1000589", "name": "contact email", "value": "fangf@shanghaitech.edu.cn"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "ShanghaiTech University"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "http://download.iprox.org/IPX0003508000/IPX0003508002/630120-1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "http://download.iprox.org/IPX0003508000/IPX0003508002/630120-2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "http://download.iprox.org/IPX0003508000/IPX0003508002/630121-1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "http://download.iprox.org/IPX0003508000/IPX0003508002/630121-2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "http://download.iprox.org/IPX0003508000/IPX0003508002/DMSO1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "http://download.iprox.org/IPX0003508000/IPX0003508002/DMSO2.raw"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "http://download.iprox.org/IPX0003508000/IPX0003508002/proteinGroups.xlsx"}], "description": "The rate-limiting enzyme of salvage pathway for NAD+ synthesis, NAMPT, is aberrantly overexpressed in a variety of tumor cells and is a poor prognosis factor for patient survival. NAMPT plays a major role in tumor cell proliferation, acting concurrently as a NAD+ synthase and unexpectedly, an extracellular ligand for several tumor-promoting signaling pathway.\u00a0While previous efforts to modulate NAMPT activity were limited to enzymatic inhibitors with low success in clinical studies, protein degradation offers a possibility to simultaneously disrupt NAMPT\u2019s enzyme activity and ligand capabilities. Here, we report the development of two highly selective NAMPT-targeted proteolysis-targeting chimeras (PROTACs), which promoted rapid and potent NAMPT degradation in a cereblon-dependent manner in multiple tumor cell lines. Notably, both PROTAC degraders outperform a clinical candidate, FK866, in killing effect on hematological tumor cells. These results emphasize the importance and feasibility of applying PROTACs as a better strategy for targeting proteins like NAMPT with dual tumor-promoting functions, which are not easily achieved by conventional enzymatic inhibitors.", "fullDatasetLinks": [{"accession": "MS:1002837", "name": "iProX dataset URI", "value": "http://www.iprox.org/page/project.html?id=IPX0003508000"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD028453"}, {"accession": "MS:1002836", "name": "iProX dataset identifier", "value": "IPX0003508000"}], "instruments": [{"accession": "MS:1002877", "name": "Q Exactive HF-X"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "PROTAC, iNAMPT, eNAMPT, enzymatic-independent, NAD+"}], "modifications": [{"accession": "MS:1002864", "name": "No PTMs are included in the dataset"}], "publications": [{"terms": [{"accession": "MS:1002858", "name": "Dataset with its publication pending"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Addressing Enzymatic-Independent Tumor-Promoting Function of NAMPT via PROTAC-Mediated Degradation"}